Skip to main content


Fig. 2 | Cancer Communications

Fig. 2

From: Identification of genetic alterations associated with primary resistance to EGFR-TKIs in advanced non-small-cell lung cancer patients with EGFR sensitive mutations

Fig. 2

Kaplan-Meier curves of the progression-free survival (PFS) and overall survival (OS) for NSCLC patients with RG alterations. PFS (a) and OS (b) were analyzed in the 416 NSCLC patients, according to the RG alterations. In the subgroups of NSCLC patients that were EGFR+/RG−, EGFR+/RG+, EGFR−, PFS (c) and OS (d) were analyzed. The survival rates were compared using the log-rank test. NSCLC non-small cell lung cancer, PFS progression-free survival, OS overall survival, RG resistance gene

Back to article page